Target intelligence / Profile preview

Gut microbiome composition alteration (null)

Target
null
Molecular classification
Other (not a molecule, receptor, enzyme, or protein; refers to a state or process)
01

Overview

"Gut microbiome composition alteration" does not refer to a single molecular target but rather describes changes—often termed "dysbiosis"—in the community structure of microorganisms residing in the gastrointestinal tract. These alterations can be caused by factors such as diet, antibiotics, environmental exposures, age, genetics, stressors, and underlying health conditions. The gut microbiota plays essential roles in digestion; nutrient absorption; energy harvest; vitamin synthesis; modulation of inflammation; maintenance of intestinal barrier integrity; regulation via the gut-brain axis affecting neurological health; and protection against pathogens.[1][3][4] Persistent alterations are linked to various diseases including inflammatory bowel disease,[1] metabolic disorders like diabetes,[5] neurodegenerative conditions such as Alzheimer’s,[4] liver diseases,[1] cardiovascular complications,[5], among others. Therapeutic strategies do not target "gut microbiome composition alteration" directly as one would a receptor or enzyme but instead aim to restore healthy balance through interventions like probiotics/prebiotics administration,[7], fecal transplants,[2], dietary modification,[1], lifestyle changes,[4], or selective use/reduction of antibiotics.[6]. While these approaches show promise across multiple indications—including gastrointestinal disorders like IBS [7], neurodegeneration [4], diabetes [5], radiation-induced injury [3], etc.—the field faces challenges regarding efficacy reproducibility between individuals/populations and potential safety risks associated with manipulating complex microbial ecosystems.[2]. Because "gut microbiome composition alteration" is not itself a discrete molecular entity but rather an ecosystem-level phenomenon/process/state—and because it cannot be classified under standard molecular families—it is considered an incorrect entry if intended as a canonical drug target.

Other names
Altered gut microbiomeGut microbiota dysbiosisMicrobiome imbalanceDysbiosis of gut microbes
02

Mechanism of action

Mechanisms for drugs/interventions targeting this process include: - Restoration of microbial diversity and balance via probiotics/prebiotics/fecal transplant[2][4][7] - Suppression or elimination of pathogenic bacteria with antibiotics or bacteriotherapy[2] - Modulation of microbial metabolites that influence host metabolism and immune function (e.g., short-chain fatty acids, sphingolipids)[3][4]

03

Biological functions

Digestion and nutrient absorption[1]Energy harvest[1]Vitamin synthesis[1]Modulation of inflammation and immune response[1][2][4]Maintenance of intestinal barrier integrity[3]
04

Disease associations

Inflammation (e.g., IBD)[1][2][3]Metabolic diseases (obesity, diabetes)[1][5]Neurodegenerative disease (Alzheimer’s disease, Parkinson’s disease)[2][4]Liver diseases[1]Cardiovascular disease (via chronic inflammation)[5]
05

Safety considerations

Difficulty in selecting effective therapeutic schemes due to individual variabilityContradictory results from small sample sizesUnclear long-term side effects from microbial therapiesPotential risk for unintended infections or adverse metabolic effects
06

Interacting drugs

Bifidobacterium breve

6 more in the full profile.

Beyond the preview

Go deeper on Gut microbiome composition alteration (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiome composition alteration (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call